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Four Methods for Glucose Assay Compared for Various Glucose Concentrations and under Different Clinical Conditions
Ottavio Giampietro, Alessandro P110,Giuseppe Buzzigoli, Claudlo Boni, and Renzo Navalesi
Glucose was measured by the ferricyanide, the Beckman glucose oxidase, and the hexokinase procedures in 228 plasma samples taken during standard oral glucose-tolerance tests in 17 normal subjects and in 21 chemical diabetics. The neocuproine method was also used to measure glucose concentration in 156 samples (78 before and 78 after dialysis) collected from six diabetic and uremic patients who were on maintenance hemodialysis. Ferncyanide in all conditions and neocuproine in uremic patients overestimated glucose concentrations over the entire experimental range as compared with either enzymic method. This bias or systematic error of the reducing vs the enzymic procedures, due to nonglucose reducing substances ("saccharoids"), becomes considerably greater when their concentration is increased as in chronic uremia. Also, the inverse relation between glucose concentration and overestimation of glucose by the reducing methods has been detected. With respect to the hexokinase method, a mild but significant underestimate of glucose oxidase readings has been observed for higher glucose concentrations. We find neocuproine to be the most imprecise of these procedures. 
Materials and Methods
Results
Because results by the various analytical procedures for normal individuals and the diabetics were superimposable, we show in Figure 1 
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glucosevalues<1.00 g/L, when hexokinase gives higher values. As for uremics: (a) Before dialysis (Figure 2a) both of the reducing methods significantly overestimate-
Discussion
We used the glucoseoxidasemethod as the comparison method because of its better precision and practicability in our laboratory. Moreover,itreportedly (3, 9, 10 ) is a stable method, specific for glucose, uninfluenced by the interfering substances thatareespecially presentin the uremic samples. Our data confirm that ferricyanide gives higherglucose values than enzymicmethods do,both under normal conditions and when therearemany circulating interfering substances. The fernicyanide-assay error due to nonglucosereducingsubstances becomes considerably greater when their concentration is increased as in chronic uremia. Clearly, the positive bias shown by the ferricyanide method is much higher in uremic patients before dialysis, decreases after dialysis, and is much less in chemical diabetics.
Limited to uremic patients, similar
conclusions can be drawn forneocuproine, which gives higher around 0.80-1.20 g/L) and so theirconclusions may not be justified forhigherbloodglucose concentrations. In the other (5.3%) paper (3), from the experimentaldata (see Table 3 Resultsby thehexokinasemethod aregenerally verynear to those of glucose oxidase, but tend to be a little lowerinall (+ 11.2%) (+ 10.5%) clinical conditions-and become significantly loweraround In conclusion, our data confirm that reducing procedures forglucoseassayshouldbe discontinued (3, 9, 10) , because (+4.1 #{176}") they are strongly affected by interfering substancesand (to a lesser degree) also by glucose concentration excursions. Thus these methods may involveerrorsin the glucosereadings mainly in conditions of "borderline" carbohydrateabnormality. The significance of the differences of each value from the glucose oxidase value shown in the heading of the columns has been computed from the conf Idence limits of the respective regression lines. >0p<0.01; #{176}p 0.05. readings than glucose oxidase both before and after dialysis, although less so than fernicyanide. Finally, the positive bias of reducing vs enzymic procedures remains higher in dialysed uremics than the biasin normals,as would be expectedif circulating interferences in chronic uremia are not completely removed by thesingle dialysis.
The relation between glucoseconcentration and overestimation of glucose by the reducing methods should be noted.
Reportedly (9) the positive percent bias of neocuproine is related to the glucose concentration, that forglucoseconcentrations of 0.90-1.00 g/L being about twice that observed for concentrations of 2.80-3.00 g/L (9). These data, which were obtained on control sera (9) ,are confirmedby our data on uremic samples. Moreover, fernicyanide gives higher glucose readings than does glucoseoxidase, thedifference beingapproximately constant in grams per liter, both in normal conditions and in the presence of many interfering substances (before and after dialysis); evidently the percent error by the ferricyanide method is higher at lower glucose concentrations (8, 29, and 20%, respectively, in chemical diabetics, in uremics before dialysis, and in uremics after dialysis, at 1.00 g of glucose per liter) and becomes lower at higher glucose concentrations (3, 15 , and 9% in the three groups at 2.00 g of glucose per liter). These data do not accord with some others (3, 11 
